Source: Markets Insider

Kuros Biosciences AG: Kuros Biosciences continues strong commercial roll-out of MagnetOs bone graft

Kuros Biosciences AG / Key word(s): Quarter Results Kuros Biosciences continues strong commercial roll-out of MagnetOs bone graft 27-Apr-2022...

Read full article »
Kuros Biosciences AG's Competitors | Kuros Biosciences AG's News | Kuros Biosciences AG's Financials
Stay up-to-date with the latest news on Kuros Biosciences AG
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Joost De Bruijn's photo - CEO of Kuros Biosciences AG

CEO

Joost De Bruijn

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Kuros Biosciences AG